These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 23830367

  • 1. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
    Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Surg Res; 2013 Sep; 184(1):605-12. PubMed ID: 23830367
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.
    Uwagawa T, Chiao PJ, Gocho T, Hirohara S, Misawa T, Yanaga K.
    Anticancer Res; 2009 Aug; 29(8):3173-8. PubMed ID: 19661331
    [Abstract] [Full Text] [Related]

  • 3. New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.
    Horiuchi T, Uwagawa T, Shirai Y, Saito N, Iwase R, Haruki K, Shiba H, Ohashi T, Yanaga K.
    J Surg Res; 2016 Nov; 206(1):1-8. PubMed ID: 27916347
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice.
    Fujiwara Y, Shiba H, Iwase R, Haruki K, Furukawa K, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Am Coll Surg; 2013 Feb; 216(2):320-32.e3. PubMed ID: 23219147
    [Abstract] [Full Text] [Related]

  • 5. Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
    Takada N, Sugano H, Shirai Y, Saito N, Hamura R, Taniai T, Uwagawa T, Yanaga K, Ikegami T, Ohashi T, Eto K.
    PLoS One; 2021 Feb; 16(9):e0257019. PubMed ID: 34473771
    [Abstract] [Full Text] [Related]

  • 6. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y, Wang J, Xia N, Li B, Jiang X.
    Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
    [Abstract] [Full Text] [Related]

  • 7. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D.
    J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model.
    Furukawa K, Iida T, Shiba H, Fujiwara Y, Uwagawa T, Shimada Y, Misawa T, Ohashi T, Yanaga K.
    Oncol Rep; 2010 Oct; 24(4):843-50. PubMed ID: 20811662
    [Abstract] [Full Text] [Related]

  • 9. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
    Zhang DC, Liu JL, Ding YB, Xia JG, Chen GY.
    Acta Pharmacol Sin; 2013 Feb; 34(2):301-8. PubMed ID: 23274410
    [Abstract] [Full Text] [Related]

  • 10. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.
    Holcomb BK, Yip-Schneider MT, Waters JA, Beane JD, Crooks PA, Schmidt CM.
    J Gastrointest Surg; 2012 Jul; 16(7):1333-40. PubMed ID: 22618517
    [Abstract] [Full Text] [Related]

  • 11. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B.
    Cancer Prev Res (Phila); 2016 Mar; 9(3):234-44. PubMed ID: 26667450
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX, Ju HQ, Wang F, Chen LZ, Wu QN, Sheng H, Mo HY, Pan ZZ, Xie D, Kang TB, Chen G, Yun JP, Zeng ZL, Xu RH.
    Cancer Lett; 2016 Sep 28; 380(1):87-97. PubMed ID: 27322737
    [Abstract] [Full Text] [Related]

  • 13. Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
    Denlinger CE, Rundall BK, Keller MD, Jones DR.
    Ann Thorac Surg; 2004 Oct 28; 78(4):1207-14; discussion 1207-14. PubMed ID: 15464472
    [Abstract] [Full Text] [Related]

  • 14. Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.
    Yang MH, Lee KT, Yang S, Lee JK, Lee KH, Moon IH, Rhee JC.
    J Cancer Res Clin Oncol; 2012 Oct 28; 138(10):1743-51. PubMed ID: 22699931
    [Abstract] [Full Text] [Related]

  • 15. Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer.
    Shirai Y, Shiba H, Iwase R, Haruki K, Fujiwara Y, Furukawa K, Uwagawa T, Ohashi T, Yanaga K.
    Cancer Lett; 2016 Jan 28; 370(2):177-84. PubMed ID: 26546875
    [Abstract] [Full Text] [Related]

  • 16. Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.
    Furukawa K, Ohashi T, Haruki K, Fujiwara Y, Iida T, Shiba H, Uwagawa T, Kobayashi H, Yanaga K.
    Cancer Lett; 2011 Jul 01; 306(1):92-8. PubMed ID: 21482023
    [Abstract] [Full Text] [Related]

  • 17. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH, Chen H, Guo HC, Tong HF, Liu JX, Wei WT, Tan W, Ni ZL, Liu HB, Lin SZ.
    Int J Oncol; 2011 Nov 01; 39(5):1123-31. PubMed ID: 21743963
    [Abstract] [Full Text] [Related]

  • 18. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.
    Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B.
    J Cancer Res Clin Oncol; 2012 May 01; 138(5):785-97. PubMed ID: 22270965
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice.
    Mita Y, Ajiki T, Kamigaki T, Okazaki T, Hori H, Horiuchi H, Hirata K, Fujita T, Fujimori T, Kuroda Y.
    Ann Surg Oncol; 2007 Apr 01; 14(4):1374-80. PubMed ID: 17235714
    [Abstract] [Full Text] [Related]

  • 20. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2005 Oct 01; 65(19):9064-72. PubMed ID: 16204081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.